カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のペメトレキセド薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pemetrexed Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19523）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19523
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のペメトレキセド薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ペメトレキセド薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のペメトレキセド薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ペメトレキセド薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・凍結乾燥粉末100mg/バイアル、凍結乾燥粉末500mg/バイアル

用途別セグメントは次のように区分されます。
・胸膜中皮腫、非小細胞肺がん

世界のペメトレキセド薬物市場の主要な市場プレーヤーは以下のとおりです。
・Eli Lilly and Company、Pfizer、Teva、Eagle Pharmaceuticals、APOTEX、Qilu Pharmaceutical、Biocon

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ペメトレキセド薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なペメトレキセド薬物メーカーの企業概要、2019年～2022年までのペメトレキセド薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なペメトレキセド薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ペメトレキセド薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのペメトレキセド薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペメトレキセド薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびペメトレキセド薬物の産業チェーンを掲載しています。
・第13、14、15章では、ペメトレキセド薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ペメトレキセド薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：凍結乾燥粉末100mg/バイアル、凍結乾燥粉末500mg/バイアル
- 用途別分析（2017年vs2021年vs2028年）：胸膜中皮腫、非小細胞肺がん
- 世界のペメトレキセド薬物市場規模・予測
- 世界のペメトレキセド薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Eli Lilly and Company、Pfizer、Teva、Eagle Pharmaceuticals、APOTEX、Qilu Pharmaceutical、Biocon
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：凍結乾燥粉末100mg/バイアル、凍結乾燥粉末500mg/バイアル
・用途別分析2017年-2028年：胸膜中皮腫、非小細胞肺がん
・ペメトレキセド薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ペメトレキセド薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ペメトレキセド薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ペメトレキセド薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ペメトレキセド薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pemetrexed Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pemetrexed Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pleural mesothelioma accounting for % of the Pemetrexed Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 100 mg lyophilized powder/vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pemetrexed Drug include Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, and APOTEX, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pemetrexed Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
Market segment by Application can be divided into
Pleural mesothelioma
Non-small cell lung cancer
The key market players for global Pemetrexed Drug market are listed below:
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pemetrexed Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pemetrexed Drug, with price, sales, revenue and global market share of Pemetrexed Drug from 2019 to 2022.
Chapter 3, the Pemetrexed Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pemetrexed Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pemetrexed Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pemetrexed Drug.
Chapter 13, 14, and 15, to describe Pemetrexed Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pemetrexed Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pemetrexed Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 100 mg lyophilized powder/vial
1.2.3 500 mg lyophilized powder/vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Pemetrexed Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Global Pemetrexed Drug Market Size & Forecast
1.4.1 Global Pemetrexed Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pemetrexed Drug Sales in Volume (2017-2028)
1.4.3 Global Pemetrexed Drug Price (2017-2028)
1.5 Global Pemetrexed Drug Production Capacity Analysis
1.5.1 Global Pemetrexed Drug Total Production Capacity (2017-2028)
1.5.2 Global Pemetrexed Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pemetrexed Drug Market Drivers
1.6.2 Pemetrexed Drug Market Restraints
1.6.3 Pemetrexed Drug Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Pemetrexed Drug Product and Services
2.1.4 Eli Lilly and Company Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pemetrexed Drug Product and Services
2.2.4 Pfizer Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Pemetrexed Drug Product and Services
2.3.4 Teva Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Eagle Pharmaceuticals
2.4.1 Eagle Pharmaceuticals Details
2.4.2 Eagle Pharmaceuticals Major Business
2.4.3 Eagle Pharmaceuticals Pemetrexed Drug Product and Services
2.4.4 Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 APOTEX
2.5.1 APOTEX Details
2.5.2 APOTEX Major Business
2.5.3 APOTEX Pemetrexed Drug Product and Services
2.5.4 APOTEX Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Pemetrexed Drug Product and Services
2.6.4 Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business
2.7.3 Biocon Pemetrexed Drug Product and Services
2.7.4 Biocon Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pemetrexed Drug Breakdown Data by Manufacturer
3.1 Global Pemetrexed Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pemetrexed Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pemetrexed Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Pemetrexed Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Pemetrexed Drug Manufacturer Market Share in 2021
3.5 Global Pemetrexed Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pemetrexed Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pemetrexed Drug Market Size by Region
4.1.1 Global Pemetrexed Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Pemetrexed Drug Revenue by Region (2017-2028)
4.2 North America Pemetrexed Drug Revenue (2017-2028)
4.3 Europe Pemetrexed Drug Revenue (2017-2028)
4.4 Asia-Pacific Pemetrexed Drug Revenue (2017-2028)
4.5 South America Pemetrexed Drug Revenue (2017-2028)
4.6 Middle East and Africa Pemetrexed Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pemetrexed Drug Sales in Volume by Type (2017-2028)
5.2 Global Pemetrexed Drug Revenue by Type (2017-2028)
5.3 Global Pemetrexed Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pemetrexed Drug Sales in Volume by Application (2017-2028)
6.2 Global Pemetrexed Drug Revenue by Application (2017-2028)
6.3 Global Pemetrexed Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pemetrexed Drug Sales by Type (2017-2028)
7.2 North America Pemetrexed Drug Sales by Application (2017-2028)
7.3 North America Pemetrexed Drug Market Size by Country
7.3.1 North America Pemetrexed Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Pemetrexed Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pemetrexed Drug Sales by Type (2017-2028)
8.2 Europe Pemetrexed Drug Sales by Application (2017-2028)
8.3 Europe Pemetrexed Drug Market Size by Country
8.3.1 Europe Pemetrexed Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Pemetrexed Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pemetrexed Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Pemetrexed Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Pemetrexed Drug Market Size by Region
9.3.1 Asia-Pacific Pemetrexed Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pemetrexed Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pemetrexed Drug Sales by Type (2017-2028)
10.2 South America Pemetrexed Drug Sales by Application (2017-2028)
10.3 South America Pemetrexed Drug Market Size by Country
10.3.1 South America Pemetrexed Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Pemetrexed Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pemetrexed Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Pemetrexed Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Pemetrexed Drug Market Size by Country
11.3.1 Middle East & Africa Pemetrexed Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pemetrexed Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pemetrexed Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pemetrexed Drug
12.3 Pemetrexed Drug Production Process
12.4 Pemetrexed Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pemetrexed Drug Typical Distributors
13.3 Pemetrexed Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pemetrexed Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pemetrexed Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company Major Business
Table 5. Eli Lilly and Company Pemetrexed Drug Product and Services
Table 6. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Pemetrexed Drug Product and Services
Table 10. Pfizer Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Pemetrexed Drug Product and Services
Table 14. Teva Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Eagle Pharmaceuticals Major Business
Table 17. Eagle Pharmaceuticals Pemetrexed Drug Product and Services
Table 18. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. APOTEX Basic Information, Manufacturing Base and Competitors
Table 20. APOTEX Major Business
Table 21. APOTEX Pemetrexed Drug Product and Services
Table 22. APOTEX Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Pemetrexed Drug Product and Services
Table 26. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Biocon Basic Information, Manufacturing Base and Competitors
Table 28. Biocon Major Business
Table 29. Biocon Pemetrexed Drug Product and Services
Table 30. Biocon Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Pemetrexed Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Pemetrexed Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Pemetrexed Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Pemetrexed Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Pemetrexed Drug Production Site of Key Manufacturer
Table 36. Pemetrexed Drug New Entrant and Capacity Expansion Plans
Table 37. Pemetrexed Drug Mergers & Acquisitions in the Past Five Years
Table 38. Global Pemetrexed Drug Sales by Region (2017-2022) & (K Units)
Table 39. Global Pemetrexed Drug Sales by Region (2023-2028) & (K Units)
Table 40. Global Pemetrexed Drug Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Pemetrexed Drug Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 43. Global Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 44. Global Pemetrexed Drug Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Pemetrexed Drug Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Pemetrexed Drug Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Pemetrexed Drug Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 49. Global Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 50. Global Pemetrexed Drug Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Pemetrexed Drug Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Pemetrexed Drug Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Pemetrexed Drug Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Pemetrexed Drug Sales by Country (2017-2022) & (K Units)
Table 55. North America Pemetrexed Drug Sales by Country (2023-2028) & (K Units)
Table 56. North America Pemetrexed Drug Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Pemetrexed Drug Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 59. North America Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 60. North America Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 61. North America Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 62. Europe Pemetrexed Drug Sales by Country (2017-2022) & (K Units)
Table 63. Europe Pemetrexed Drug Sales by Country (2023-2028) & (K Units)
Table 64. Europe Pemetrexed Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Pemetrexed Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 67. Europe Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 68. Europe Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 69. Europe Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Pemetrexed Drug Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Pemetrexed Drug Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Pemetrexed Drug Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Pemetrexed Drug Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 78. South America Pemetrexed Drug Sales by Country (2017-2022) & (K Units)
Table 79. South America Pemetrexed Drug Sales by Country (2023-2028) & (K Units)
Table 80. South America Pemetrexed Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Pemetrexed Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 83. South America Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 84. South America Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 85. South America Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Pemetrexed Drug Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Pemetrexed Drug Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Pemetrexed Drug Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Pemetrexed Drug Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Pemetrexed Drug Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Pemetrexed Drug Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Pemetrexed Drug Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Pemetrexed Drug Sales by Application (2023-2028) & (K Units)
Table 94. Pemetrexed Drug Raw Material
Table 95. Key Manufacturers of Pemetrexed Drug Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Pemetrexed Drug Typical Distributors
Table 99. Pemetrexed Drug Typical Customers
List of Figures
Figure 1. Pemetrexed Drug Picture
Figure 2. Global Pemetrexed Drug Revenue Market Share by Type in 2021
Figure 3. 100 mg lyophilized powder/vial
Figure 4. 500 mg lyophilized powder/vial
Figure 5. Global Pemetrexed Drug Revenue Market Share by Application in 2021
Figure 6. Pleural mesothelioma
Figure 7. Non-small cell lung cancer
Figure 8. Global Pemetrexed Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Pemetrexed Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Pemetrexed Drug Sales (2017-2028) & (K Units)
Figure 11. Global Pemetrexed Drug Price (2017-2028) & (USD/Unit)
Figure 12. Global Pemetrexed Drug Production Capacity (2017-2028) & (K Units)
Figure 13. Global Pemetrexed Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Pemetrexed Drug Market Drivers
Figure 15. Pemetrexed Drug Market Restraints
Figure 16. Pemetrexed Drug Market Trends
Figure 17. Global Pemetrexed Drug Sales Market Share by Manufacturer in 2021
Figure 18. Global Pemetrexed Drug Revenue Market Share by Manufacturer in 2021
Figure 19. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Pemetrexed Drug Sales Market Share by Region (2017-2028)
Figure 23. Global Pemetrexed Drug Revenue Market Share by Region (2017-2028)
Figure 24. North America Pemetrexed Drug Revenue (2017-2028) & (USD Million)
Figure 25. Europe Pemetrexed Drug Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Pemetrexed Drug Revenue (2017-2028) & (USD Million)
Figure 27. South America Pemetrexed Drug Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Pemetrexed Drug Revenue (2017-2028) & (USD Million)
Figure 29. Global Pemetrexed Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Pemetrexed Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Pemetrexed Drug Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Pemetrexed Drug Revenue Market Share by Application (2017-2028)
Figure 34. Global Pemetrexed Drug Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Pemetrexed Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Pemetrexed Drug Sales Market Share by Country (2017-2028)
Figure 38. North America Pemetrexed Drug Revenue Market Share by Country (2017-2028)
Figure 39. United States Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Pemetrexed Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Pemetrexed Drug Sales Market Share by Country (2017-2028)
Figure 45. Europe Pemetrexed Drug Revenue Market Share by Country (2017-2028)
Figure 46. Germany Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Pemetrexed Drug Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Pemetrexed Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pemetrexed Drug Revenue Market Share by Region (2017-2028)
Figure 55. China Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Pemetrexed Drug Sales Market Share by Type (2017-2028)
Figure 62. South America Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 63. South America Pemetrexed Drug Sales Market Share by Country (2017-2028)
Figure 64. South America Pemetrexed Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Pemetrexed Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Pemetrexed Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Pemetrexed Drug Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Pemetrexed Drug Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Pemetrexed Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Pemetrexed Drug in 2021
Figure 76. Manufacturing Process Analysis of Pemetrexed Drug
Figure 77. Pemetrexed Drug Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19523 )"世界のペメトレキセド薬物市場2022年：市場規模予測（～2028年）" (英文：Global Pemetrexed Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。